BPH MIST: the international opportunity.
Global demand is shifting toward BPH treatments that are easier to explain, simpler to adopt, and backed by clear manufacturing disclosure. Nexusuro sits at the intersection of clinical differentiation and partner-ready transparency.
Why this opportunity exists
BPH is a global aging-related condition. But the market opportunity isn't just about patient numbers — it's about changing clinical preferences and healthcare delivery models. Hospitals and clinics are increasingly asking:
- — Can we reduce tissue thermal damage?
- — Can we avoid permanent implants?
- — Is the procedure suitable for outpatient and short-stay settings?
- — Is the value proposition easy to communicate to patients?
What's driving demand internationally
| Driver | What it means for partners |
|---|---|
| Patient expectations rising | Patients increasingly research recovery time, sexual function impact, and whether implants stay in the body — creating pull for differentiated MIST options. |
| Institutions optimizing workflows | Hospitals and day-surgery centers favor procedures with low equipment barriers, short learning curves, and predictable post-op management. |
| Physicians seeking differentiated tools | Urologists are evaluating non-thermal, non-implant mechanisms as complementary additions to their existing MIST portfolio. |
| Distributors diversifying portfolios | International distributors are actively looking for BPH products with clear clinical narratives and transparent manufacturing disclosure. |
Where Nexusuro fits
In the international BPH MIST landscape, Nexusuro is positioned as an international product brand and partnership platform. This means two things for potential partners: a consistent global brand for market communication, and a focused product path built around non-thermal, non-implant differentiation.
Non-thermal
No tissue burning — avoids thermal complications and preserves anatomy
Non-implant
Nothing left behind — eliminates implant anxiety and MRI concerns
Clear disclosure
Transparent manufacturing, NMPA, and ISO 13485 documentation
Global brand
Consistent Nexusuro branding for all international market communication
Who is best positioned to evaluate this
International distributors
For partners with existing urology sales networks seeking a differentiated BPH product with clear clinical positioning and manageable regulatory pathway.
Hospitals & day surgery centers
For institutions evaluating non-thermal, non-implant BPH paths — particularly those building or expanding outpatient urology services.
Specialty clinics
For urology-focused clinics looking to add a differentiated, easy-to-adopt MIST option with minimal equipment investment.
Partnership overview How the technology works Clinical evidence
Ready to evaluate the opportunity?
Start a conversation with our partnership team. No commitment — just an informed first discussion.
This page provides industry and product information for reference purposes only and does not constitute an investment offer or commercial commitment. Partnership terms are subject to separate written agreement.